Operating Income (Loss) in USD of AGILE THERAPEUTICS INC from 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Agile Therapeutics Inc quarterly/annual Operating Income (Loss) history and change rate from 2012 to Q2 2024.
  • Agile Therapeutics Inc Operating Income (Loss) for the quarter ending 30 Jun 2024 was -$2.75M, a 46.4% increase year-over-year.
  • Agile Therapeutics Inc Operating Income (Loss) for the twelve months ending 30 Jun 2024 was -$13.6M, a 63.8% increase year-over-year.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2023 was -$19.9M, a 62.2% increase from 2022.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2022 was -$52.6M, a 26% increase from 2021.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2021 was -$71M, a 44.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$13.6M -$2.75M +$2.38M +46.4% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 -$15.9M -$2.76M +$3.95M +58.9% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$19.9M -$4.05M +$2.83M +41.1% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 -$22.7M -$4M +$14.7M +78.6% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 -$37.4M -$5.13M +$6.27M +55% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$43.7M -$6.71M +$8.87M +56.9% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$52.6M -$6.88M +$15.5M +69.2% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$68M -$18.7M -$2.93M -18.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$65.1M -$11.4M +$5.25M +31.5% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$70.4M -$15.6M +$649K +4% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$71M -$22.4M -$5.62M -33.6% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 -$65.4M -$15.8M -$1.12M -7.63% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$64.3M -$16.7M -$6.61M -65.9% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$57.7M -$16.2M -$8.61M -113% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$49.1M -$16.7M -$10.6M -174% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2023
Q3 2020 -$38.4M -$14.7M -$10.2M -226% 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q2 2020 -$28.3M -$10M -$6.49M -183% 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021
Q1 2020 -$21.8M -$7.62M -$2.91M -61.8% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 -$18.9M -$6.11M -$2.38M -63.8% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2022
Q3 2019 -$16.5M -$4.5M -$884K -24.5% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$15.6M -$3.55M +$1.6M +31.1% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$17.2M -$4.71M +$2.34M +33.2% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q4 2018 -$19.5M -$3.73M +$2.26M +37.8% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021
Q3 2018 -$21.8M -$3.62M +$3.09M +46.1% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019
Q2 2018 -$24.9M -$5.15M +$1.85M +26.4% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 -$26.7M -$7.05M +$80K +1.12% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 -$26.8M -$5.99M +$1.82M +23.3% 01 Oct 2017 31 Dec 2017 10-K 20 Feb 2020
Q3 2017 -$28.6M -$6.7M +$390K +5.5% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 -$29M -$7M +$845K +10.8% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018
Q1 2017 -$29.9M -$7.13M -$146K -2.09% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018
Q4 2016 -$29.7M -$7.81M +$1.36M +14.8% 01 Oct 2016 31 Dec 2016 10-K 12 Mar 2019
Q3 2016 -$31.1M -$7.09M +$1.87M +20.9% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 -$33M -$7.84M +$140K +1.75% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017
Q1 2016 -$33.1M -$6.98M -$3K -0.04% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q4 2015 -$33.1M -$9.17M -$2.64M -40.5% 01 Oct 2015 31 Dec 2015 10-K 12 Mar 2018
Q3 2015 -$30.4M -$8.97M -$2.92M -48.2% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 -$27.5M -$7.98M -$4.49M -128% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016
Q1 2015 -$23M -$6.98M -$4.53M -185% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$18.5M -$6.52M 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2017
Q3 2014 -$6.05M -$2.73M -82.1% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 -$3.49M -$246K -7.56% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 -$2.45M 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015
Q3 2013 -$3.32M 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$3.25M 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014

AGILE THERAPEUTICS INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$19.9M +$32.7M +62.2% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 -$52.6M +$18.4M +26% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$71M -$22M -44.8% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 -$49.1M -$30.2M -160% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
2019 -$18.9M +$677K +3.47% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 -$19.5M +$7.28M +27.1% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 -$26.8M +$2.91M +9.79% 01 Jan 2017 31 Dec 2017 10-K 20 Feb 2020
2016 -$29.7M +$3.37M +10.2% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 -$33.1M -$14.6M -78.7% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018
2014 -$18.5M -$5.79M -45.5% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017
2013 -$12.7M +$10.6M +45.4% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016
2012 -$23.3M 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.